Joint Commission o f P harmacy PractitionersAcademy of Managed Care Pharmacy 703-683-8416 Edith Rosato, Chief Executive Officer American College of Apothecaries 901-383-8119 Ed Hesterlee
Trang 1Joint Commission o f P harmacy Practitioners
Academy of Managed Care Pharmacy
703-683-8416
Edith Rosato, Chief Executive Officer
American College of Apothecaries
901-383-8119
Ed Hesterlee, Executive Vice President
American College of Clinical Pharmacy
816-531-2177
Michael S Maddux, Executive Director
American Pharmacists Association
202-628-4410
Thomas E Menighan, Executive Vice President
American Society of Consultant Pharmacists
703-739-1300
Frank Grosso, Chief Executive Officer
American Society of Health-System Pharmacists
301-664-8890
Paul Abramowitz, Chief Executive Officer
National Community Pharmacists Association
703-683-8200 Douglas Hoey, Chief Executive Officer
Liaison Members
Accreditation Council for Pharmacy Education
312-664-3575 Peter H Vlasses, Executive Director
American Association of Colleges of Pharmacy
703-739-2330 Lucinda L Maine, Executive Vice President
National Alliance of State Pharmacy Associations
804-285-4431
Rebecca P Snead, Executive Vice President
National Association of Boards of Pharmacy
847-391-4400 Carmen A Catizone, Executive Director
Summary of Discussion –August 21, 2014
55 Attendees
Representing member organizations: (19)
Academy of Managed Care Pharmacy
Edith Rosato, Chief Executive Officer
Dana McCormick, President
Accreditation Council for Pharmacy Education
Peter Vlasses, Executive Director
Stephanie Gardner, President
American Association of Colleges of Pharmacy
Lucinda Maine, Executive Vice President
Pat Chase, President
American College of Apothecaries
Ed Hesterlee, Executive Vice President
American College of Clinical Pharmacy
Michael Maddux, Executive Director
Gary Yee, President
Trang 2American Pharmacists Association
Thomas Menighan, Executive Vice President
Matt Osterhaus, President
American Society of Consultant Pharmacists
Frank Grosso, Chief Executive Officer
Jeffery Delafuente, President
American Society of Health-System Pharmacists
Paul Abramowitz, Chief Executive Officer
Christene Jolowsky, President
National Alliance of State Pharmacy Associations
Rebecca P Snead, Executive Vice President
Phil Woodward, President
National Association of Boards of Pharmacy
National Community Pharmacists Association
Doug Hoey, Chief Executive Officer
Mark Riley, President
Guests (36)
Joan Baird ((ASCP)
Lynne Batshon (ASCP)
Lynette Bradley-Baker (AACP)
Ryan Burke (JCPP/APhA)
Anne Burns (APhA)
Stephanie Callinan (ASCP)
MaryJo Carden (AMCP)
Adam Chesler (PTCB)
Addolorata Ciccone (ASCP)
Sharon Clackum (ASCP)
Arnold Clayman (ASCP)
Kevin Day (NCPA)
Lauren Fuller (AMCP)
Carolyn Ha (NCPA)
Sheldon Holstad (ACCP)
Sean Jeffery (ASCP)
Elizabeth Jex (FTC)
Ray Love (CPNP)
Stacie Maass (APhA) Everett McAllister (PTCB) Steve Mullinex (NCPDP) Jim Owen (APhA) Margaret Robinson (NASPA) Mitchel Rothholz (JCPP/APhA) Elizabeth “Scotti” Russell (NABP) Doug Scheckelhoff (ASHP)
Lisa Schwartz (NCPA) Todd Sega (AMCP) Amy Shank (PCCA) April Shaughnessy (AMCP) Mindy Smith (APhA Foundation) Todd Sorensen (AIMMc)
Ken Sprague (ASCP) Lee Ann Stember (NCPDP) Brian Wall (APhA Foundation /JCPP)
C Edwin Webb (ACCP)
Member organizations of the Joint Commission of Pharmacy Practitioners (JCPP) held their
regularly scheduled quarterly meeting on Thursday, August 21, 2014, at the Lorien Hotel, Alexandria,
Virginia Meeting participants were welcomed by Edith Rosato, AMCP CEO and Chair of this JCPP
Meeting Representatives of member organizations and guests introduced themselves
Trang 3Paul Abramowitz, ASHP CEO, provided a recognition and led a moment of silence regarding the recent passing of Janet Teeters, ASHP Director of Accreditation Services
Opening Remarks / Administrative Activity
Members reviewed and accepted the Summary of Discussion from the May 29, 2014, JCPP
meeting The participants then reviewed the 2014 JCPP meeting schedule and template agendas The
meeting agenda for the November 19, 2014, JCPP meeting was accepted and the organizations were
reminded that the registration memo was included in their meeting packets
Update on Provider Status Activities - State Based Activities
Becky Snead, NASPA CEO, provided an overview of activity at the state level to achieve provider designation and service identification, payment and coverage for services, and optimization of pharmacy practice acts She reviewed various state examples and the trends at the state level The members
discussed areas for collaboration to advance progress towards the JCPP Vision
National Patient Safety and Clinical Pharmacy Services Collaborative
Todd Sorensen, PharmD, Executive Director of the Alliance for Integrated Medication
Managrment Collaborative (AIMMc) discussed the work of AIMMc and the work conducted by
participating practices that support the profession achieving a "tipping point" on delivery of medication management services and the alignment of AIMMc to JCPP's strategic goals He discussed with the
JCPP organizations current status and direction of AIMMc and ways JCPP organizations can increase
involvement with AIMMc
Task Force Pharmacists' Role in Addressing Prescription Medication Misuse and Abuse
JCPP members reviewed the draft statement and principles on pharmacists' role in addressing
prescription medication misuse and abuse prepared by a staff working group This document is intended for use within and outside of the profession After some discussion and suggested modifications, JCPP member organizations approved the draft as amended The document is attached
NCPDP Standards and Activities Related to Pharmacy Practice
Steve Mullinex, NCPDP Senior Vice President of Public Policy and Industry Relations, and Lee Ann Stember, NCPDP President, provided an overview of the history and membership of NCPDP, their role as a neutral convener, expansion in dentistry and NCPDP activities impacting pharmacy practice
(compounding, ePrescribing, acetaminophen use and dosing, standardized dose designations,
immunizations, medication synchronization, PDMP, prior authorization, audits and best practice
initiatives)
JCPP Vision Strategic Plan
JCPP members reviewed a draft document prepared by the Strategic Planning Steering Committee The CEOs were complimentary of the work conducted by the committee A one-day planning meeting of JCPP member organization staff will be planned before the next meeting to refine the tactics contained within the plan related to the goals that JCPP will assume a leadership role and further discuss
implementation of the plan In addition, the CEOs will continue to discuss JCPP organizational structure
Trang 4to best implement the strategic plan within available resources After discussion the JCPP members
approved an amended version of the document goals and objectives
Revisiting Competition Issues in the Follow-on Biologics Arena
Elizabeth Jex, attorney advisor at the Federal Trade Commission (FTC) discussed the work of the FTC regarding consumer protection in healthcare, particularly as it relates to pharmaceuticals and
follow-on biologics She reported that specialty drugs make up approximately 50% of drug spend She reviewed current federal laws and barriers to the entry of lower cost products into the US market, including activity
on the state level
Hot Topics and Organizational Updates
No additional topic ideas for future JCPP meetings were identified at this time
Each organization reported on progress it was making in the areas of focus related to the
implementation of the JCPP Vision Strategic Plan: Patient Care Process; Pharmacy Quality; Value of
Pharmacists’ Patient Care Services; HIT; Provider Status Recognition, in addition to other organizational
information
A number of newsletters, journals, and other educational materials from practitioner organizations were provided so that member organizations may better serve pharmacy practitioners and coordinate
future projects
The next regularly scheduled meeting of JCPP is November 19, 2014; it will focus on continued discussions around activity implementation related to the new vision statement, post-election impact on pharmacy’s agenda, accreditation of pharmacy practice, and data interchange
There being no further business, the meeting was adjourned at 2:46pm
###